Literature DB >> 9163679

Role of antioxidants and intracellular free radicals in retinamide-induced cell death.

D Delia1, A Aiello, L Meroni, M Nicolini, J C Reed, M A Pierotti.   

Abstract

The cancer chemopreventive synthetic retinoid N-(4-hydroxyphenyl)retinamide (HPR) possesses antiproliferative and apoptotic activity at pharmacological doses. In this study we show that addition of antioxidants to HL-60 cells cultured in the presence of 3 microM HPR, markedly suppresses the apoptopic effect of the retinoid and significantly prolongs cell survival (48-96 h). We also show, by the use of the oxidation-sensitive probe 2',7'-dichlorofluorescin diacetate (DCF-DA) and in combination with flow cytometric and spectrofluorimetric analysis, that treatment of cells with 3 microM HPR results in an immediate and sustained production of intracellular free radicals, most likely hydroperoxides. Interestingly, the formation of these HPR-induced free radicals is effectively blocked by the water soluble antioxidants L-ascorbic acid and N-acetyl-L-cysteine. Neither 3-15 microM N-(4-methoxyphenyl) retinamide (MPR), the structurally similar but biologically inert analog of HPR, nor 3 microM doses of the retinoids all-trans retinoic acid, 9-cis-retinoic acid, TTNPB and SR11237 induce intracellular free radicals, thus indicating that the specificity of this phenomenon is restricted to HPR. Altogether, we provide the first direct evidence that HPR stimulates the generation of intracellular free radicals, which appear to have a causative role in the induction of apoptosis in vitro. Our findings raise the possibility that the therapeutic efficacy of HPR may, at least in part, depend on these apoptosis-inducing oxidative phenomena.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163679     DOI: 10.1093/carcin/18.5.943

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  13 in total

1.  All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma.

Authors:  Amareshwar T K Singh; Andrew M Evens; Reilly J Anderson; Jennifer A Beckstead; Natesan Sankar; Antonella Sassano; Savita Bhalla; Shuo Yang; Leonidas C Platanias; Trudy M Forte; Robert O Ryan; Leo I Gordon
Journal:  Br J Haematol       Date:  2010-05-09       Impact factor: 6.998

2.  Three-dimensional structure and enzymatic function of proapoptotic human p53-inducible quinone oxidoreductase PIG3.

Authors:  Sergio Porté; Eva Valencia; Evgenia A Yakovtseva; Emma Borràs; Naeem Shafqat; Judit E Debreczeny; Ashley C W Pike; Udo Oppermann; Jaume Farrés; Ignacio Fita; Xavier Parés
Journal:  J Biol Chem       Date:  2009-04-05       Impact factor: 5.157

3.  In vitro optimization of retinoic acid-induced neuritogenesis and TH endogenous expression in human SH-SY5Y neuroblastoma cells by the antioxidant Trolox.

Authors:  Mario Luiz Conte da Frota Junior; André Simões Pires; Fares Zeidán-Chuliá; Ivi Juliana Bristot; Fernanda M Lopes; Matheus Augusto de Bittencourt Pasquali; Alfeu Zanotto-Filho; Guilherme Antônio Behr; Fabio Klamt; Daniel Pens Gelain; José Cláudio Fonseca Moreira
Journal:  Mol Cell Biochem       Date:  2011-07-07       Impact factor: 3.396

4.  N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells.

Authors:  H-J Kim; N Chakravarti; N Oridate; C Choe; F-X Claret; R Lotan
Journal:  Oncogene       Date:  2006-05-04       Impact factor: 9.867

5.  Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma.

Authors:  Andrew J Cowan; Phillip A Stevenson; Ted A Gooley; Shani L Frayo; George R Oliveira; Stephen D Smith; Damian J Green; Jennifer E Roden; John M Pagel; Brent L Wood; Oliver W Press; Ajay K Gopal
Journal:  Br J Haematol       Date:  2017-01-05       Impact factor: 6.998

Review 6.  Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.

Authors:  C P Reynolds
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

Review 7.  Fenretinide and cancer prevention.

Authors:  R Torrisi; A Decensi
Journal:  Curr Oncol Rep       Date:  2000-05       Impact factor: 5.075

8.  Role for PKC δ in Fenretinide-Mediated Apoptosis in Lymphoid Leukemia Cells.

Authors:  Vivian R Ruvolo; Kul B Karanjeet; Todd F Schuster; Rhoderick Brown; Yibin Deng; Edward Hinchcliffe; Peter P Ruvolo
Journal:  J Signal Transduct       Date:  2010-01-01

9.  Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.

Authors:  Barry J Maurer; Min H Kang; Judith G Villablanca; Jitka Janeba; Susan Groshen; Katherine K Matthay; Paul M Sondel; John M Maris; Hollie A Jackson; Fariba Goodarzian; Hiroyuki Shimada; Scarlett Czarnecki; Beth Hasenauer; C Patrick Reynolds; Araz Marachelian
Journal:  Pediatr Blood Cancer       Date:  2013-06-29       Impact factor: 3.167

Review 10.  Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk?

Authors:  Massimiliano Cazzaniga; Clara Varricchio; Chiara Montefrancesco; Irene Feroce; Aliana Guerrieri-Gonzaga
Journal:  J Biomed Biotechnol       Date:  2012-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.